For 12 months the Labor cabinet has been sitting on a Pharmaceutical Benefits Advisory Committee’s decision to release a drug called Avodart which could help reduce the size of the prostate in the 400,000 Australian men suffering from the complaint. Would they be delaying approval, with no indication as to when it will be approved, if it involved women’s health?
Read More